Epigenetic reprogramming shapes the cellular landscape of schwannoma

S. John Liu, Tim Casey-Clyde, Nam Woo Cho, Jason Swinderman, Melike Pekmezci, Mark C. Dougherty, Kyla Foster, William C. Chen, Javier E. Villanueva-Meyer, Danielle L. Swaney, Harish N. Vasudevan, Abrar Choudhury, Joanna Pak, Jonathan D. Breshears, Ursula E. Lang, Charlotte D. Eaton, Kamir J. Hiam-Galvez, Erica Stevenson, Kuei Ho Chen, Brian V. LienDavid Wu, Steve E. Braunstein, Penny K. Sneed, Stephen T. Magill, Daniel Lim, Michael W. McDermott, Mitchel S. Berger, Arie Perry, Nevan J. Krogan, Marlan R. Hansen, Matthew H. Spitzer, Luke Gilbert, Philip V. Theodosopoulos, David R. Raleigh*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Mechanisms specifying cancer cell states and response to therapy are incompletely understood. Here we show epigenetic reprogramming shapes the cellular landscape of schwannomas, the most common tumors of the peripheral nervous system. We find schwannomas are comprised of 2 molecular groups that are distinguished by activation of neural crest or nerve injury pathways that specify tumor cell states and the architecture of the tumor immune microenvironment. Moreover, we find radiotherapy is sufficient for interconversion of neural crest schwannomas to immune-enriched schwannomas through epigenetic and metabolic reprogramming. To define mechanisms underlying schwannoma groups, we develop a technique for simultaneous interrogation of chromatin accessibility and gene expression coupled with genetic and therapeutic perturbations in single-nuclei. Our results elucidate a framework for understanding epigenetic drivers of tumor evolution and establish a paradigm of epigenetic and metabolic reprograming of cancer cells that shapes the immune microenvironment in response to radiotherapy.

Original languageEnglish (US)
Article number476
JournalNature communications
Volume15
Issue number1
DOIs
StatePublished - Dec 2024

Funding

The authors thank Jeremy Reiter, Monika Sigg, Aparna Bhaduri, Aaron Tward, and Zora Arum for providing comments and reagents; Eric Chow, Derek Bogdanoff, Tomasz Nowakowski, Chang Kim, and Galina Schmunk for technical sequencing assistance and analysis; and Ken Probst and Noel Sirivansanti for Illustrations. This study was supported by the ASCO Conquer Cancer Sontag Foundation Young Investigator Award to SJL; NIH grants R21 HD106238 and R01 CA251221, and DOD grant NFRP NF200021 to D.R.R.; NIH grant U54 CA209891 to N.J.K.; a Children’s Tumor Foundation Young Investigator Award to H.N.V.; and an American Otological Society Fellowship Grant to M.C.D. Sequencing was performed at the UCSF CAT, supported by UCSF PBBR, RRP IMIA, and NIH grant S10 OD028511.

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry, Genetics and Molecular Biology
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'Epigenetic reprogramming shapes the cellular landscape of schwannoma'. Together they form a unique fingerprint.

Cite this